Allergy Testing Access Act of 2021
United States117th CongressS-701Senate
Updated: Mar 11, 2021
Summary
Allergy Testing Access Act of 2021 This bill requires equal coverage of two types of allergy tests under Medicaid and Medicare. Specifically, in vitro specific IgE tests (blood tests) and percutaneous tests (skin tests) must be treated equally with respect to (1) medical necessity or other coverage requirements, (2) frequency limits, and (3) allergen unit limits.
Bill texts
All available records shown.
Timeline
Latest companion bill action
HR-4114: Allergy Testing Access Act of 2021Referred to the Subcommittee on Health.
Introduced in Senate
Read twice and referred to the Committee on Finance.
Senate
All available records shown.